# CARDEAS PHARMA Corp: Form D filings

CARDEAS PHARMA Corp, a pharmaceuticals company in Seattle, WA, filed 7 Form D notices with the SEC between 2010 and 2015. The latest, on April 9, 2015, reports $37.5 million sold of a $37.5 million offering to 21 investors.

Find out what CARDEAS PHARMA Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CARDEAS%20PHARMA%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CARDEAS%20PHARMA%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fcardeas-pharma-corp-1497414)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CARDEAS%20PHARMA%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CARDEAS%20PHARMA%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fcardeas-pharma-corp-1497414)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2025 1ST AVENUE, SUITE 1200, Seattle, WA, 98121
- Phone: (206) 973-1026
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2010
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1497414

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 9, 2015 | Amendment | $37,500,000 | $37,500,000 | $0 | 21 | May 17, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000116840415000010/0001168404-15-000010-index.htm) |
| May 23, 2013 | New notice | $34,000,000 | $34,000,000 | $0 | 21 | May 17, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000149741413000001/0001497414-13-000001-index.htm) |
| Sep 27, 2012 | Amendment | $10,535,985 | $10,527,201 | $8,784 | 12 | Dec 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000149741412000003/0001497414-12-000003-index.htm) |
| Mar 16, 2012 | Amendment | $7,535,988 | $7,535,988 | $0 | 10 | Dec 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000149741412000002/0001497414-12-000002-index.htm) |
| Dec 30, 2011 | New notice | $7,499,988 | $5,899,995 | $1,599,993 | 5 | Dec 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000149741411000003/0001497414-11-000003-index.htm) |
| Feb 22, 2011 | New notice | $1,100,000 | $1,001,523 | $98,477 | 18 | Feb 10, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000149741411000001/0001497414-11-000001-index.htm) |
| Aug 10, 2010 | New notice | $20,100 | $20,100 | $0 | 3 | Aug 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497414/000149741410000001/0001497414-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Bruce deGavre | Director |  |
| Anthony Bruce Scullion | Director |  |
| A. Bruce Montgomery | Executive Officer, Director, Promoter |  |
| Peter Bruce Moldt | Director |  |
| Kevin Bruce Kinsella | Director |  |
| Melissa Yeager | Executive Officer, Promoter |  |
| Aaron Bruce Davidson | Director |  |

## Other pharmaceuticals companies in Washington that filed recently

- [Aptevo Therapeutics Inc.](https://specstream.ai/data/form-d/company/aptevo-therapeutics-inc-1671584) $3.5 million · Aug 26, 2026

[Every Form D from the week of Apr 6, 2015](https://specstream.ai/data/form-d/week/2015-04-06) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what CARDEAS PHARMA Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).